Ticker: 600276.SS

03:27am, Tuesday, May 12, 2026

Hengrui Pharma's Stock Jumps on Massive $1B Collaboration with Bristol-Myers

Jiangsu Hengrui Pharmaceuticals' shares soared after announcing a global oncology and immunology development deal with Bristol-Myers Squibb worth up to $15.2 billion.